Friday's trading: profit taking sells and new buying on news
Interesting trading in OSIR on Friday with a little higher volume than has been typical of late. Quite possibly what we were seeing was profit taking in the form of sales of relatively larger blocks of several thousands of shares pulling the price down. Then, in the final hour, after IBD and our own thg posted on this board the favorable article about OSIR's prochymal approvals establishing OSIR as being ahead of Baxter's stem cell research, we saw lots of 100 and 200 share purchases causing the rise in the OSIR share price. I would expect some end-of-the-year profit taking could continue in the coming week. But if the positive IBD information is more widely disseminated, it will be an interesting contest to see which force prevails in the short term.